---
title: "Ezetimibe - Mixed hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db00973-mesh-d006950-1.html
toc: false 
---


Path ID: `DB00973_MESH_D006950_1`
{% include image.html url="images/db00973-mesh-d006950-1.png" file="db00973-mesh-d006950-1.png" alt="db00973-mesh-d006950-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D000069438 | ezetimibe | Drug |
| UniProt:Q9UHC9 | NPC1-like intracellular cholesterol transporter 1 | Protein |
| GO:0098856 | intestinal lipid absorption | BiologicalProcess |
| CHEBI:16113 | cholesterol | ChemicalSubstance |
| CHEBI:17855 | triglyceride | ChemicalSubstance |
| MESH:D006950 | Mixed hyperlipidemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Ezetimibe | NEGATIVELY REGULATES | Npc1-Like Intracellular Cholesterol Transporter 1 |
| Npc1-Like Intracellular Cholesterol Transporter 1 | POSITIVELY REGULATES | Intestinal Lipid Absorption |
| Intestinal Lipid Absorption | INCREASES ABUNDANCE OF | Cholesterol |
| Intestinal Lipid Absorption | INCREASES ABUNDANCE OF | Triglyceride |
| Triglyceride | POSITIVELY CORRELATED WITH | Mixed Hyperlipidemia |
| Cholesterol | POSITIVELY CORRELATED WITH | Mixed Hyperlipidemia |
|---------|-----------|---------|

Reference: 
  - [https://pharos.nih.gov/ligands/ezetimibe](https://pharos.nih.gov/ligands/ezetimibe)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/150311#section=Mechanism-of-Action](https://pubchem.ncbi.nlm.nih.gov/compound/150311#section=Mechanism-of-Action)
